New York State Common Retirement Fund’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49M Buy
109,996
+18,753
+21% +$417K ﹤0.01% 1299
2025
Q4
$2.36M Sell
91,243
-146
-0.2% -$3.47K ﹤0.01% 1332
2025
Q3
$2.36M Buy
91,389
+8,068
+10% +$198K ﹤0.01% 1381
2025
Q2
$1.99M Buy
83,321
+7,188
+9% +$181K ﹤0.01% 1416
2025
Q1
$1.89M Buy
76,133
+6,841
+10% +$164K ﹤0.01% 1394
2024
Q4
$1.31M Hold
69,292
﹤0.01% 1579
2024
Q3
$1.04M Buy
69,292
+18,596
+37% +$318K ﹤0.01% 1650
2024
Q2
$1.45M Buy
50,696
+6,804
+16% +$194K ﹤0.01% 1596
2024
Q1
$1.28M Buy
43,892
+17,880
+69% +$549K ﹤0.01% 1661
2023
Q4
$878K Sell
26,012
-7,507
-22% -$220K ﹤0.01% 1846
2023
Q3
$1.03M Sell
33,519
-10,720
-24% -$386K ﹤0.01% 1735
2023
Q2
$1.77M Buy
44,239
+1,891
+4% +$78.2K ﹤0.01% 1541
2023
Q1
$1.73M Sell
42,348
-9,376
-18% -$373K ﹤0.01% 1610
2022
Q4
$2M Buy
51,724
+81
+0.2% +$3.94K ﹤0.01% 1640
2022
Q3
$2.75M Sell
51,643
-37,241
-42% -$2.07M ﹤0.01% 1453
2022
Q2
$5.18M Sell
88,884
-74,358
-46% -$4.87M 0.01% 1182
2022
Q1
$12.5M Buy
163,242
+126,192
+341% +$8.41M 0.01% 864
2021
Q4
$2.23M Sell
37,050
-15,097
-29% -$832K ﹤0.01% 1713
2021
Q3
$2.92M Sell
52,147
-2,553
-5% -$147K ﹤0.01% 1555
2021
Q2
$3.32M Sell
54,700
-5,860
-10% -$371K ﹤0.01% 1559
2021
Q1
$4.25M Buy
60,560
+11,312
+23% +$808K ﹤0.01% 1359
2020
Q4
$2.95M Sell
49,248
-15,431
-24% -$904K ﹤0.01% 1496
2020
Q3
$3.89M Buy
64,679
+634
+1% +$36.8K ﹤0.01% 1266
2020
Q2
$3.36M Sell
64,045
-436
-0.7% -$18.2K ﹤0.01% 1315
2020
Q1
$2.16M Buy
64,481
+100
+0.2% +$4.15K ﹤0.01% 1377
2019
Q4
$2.92M Sell
64,381
-2,950
-4% -$125K ﹤0.01% 1451
2019
Q3
$2.56M Sell
67,331
-137,930
-67% -$5.51M ﹤0.01% 1515
2019
Q2
$8.93M Buy
205,261
+7,376
+4% +$313K 0.01% 1031
2019
Q1
$7.53M Buy
197,885
+18,723
+10% +$731K 0.01% 1076
2018
Q4
$7.71M Sell
179,162
-15,738
-8% -$735K 0.01% 998
2018
Q3
$9.58M Buy
194,900
+10,785
+6% +$466K 0.01% 1033
2018
Q2
$5.9M Sell
184,115
-29,896
-14% -$1.03M 0.01% 1207
2018
Q1
$6.67M Buy
214,011
+30,881
+17% +$1.1M 0.01% 1122
2017
Q4
$8.36M Buy
183,130
+16,196
+10% +$642K 0.01% 1064
2017
Q3
$6.27M Sell
166,934
-3,105
-2% -$125K 0.01% 1132
2017
Q2
$8.11M Buy
170,039
+112,263
+194% +$5.21M 0.01% 1045
2017
Q1
$2.63M Buy
57,776
+12,496
+28% +$540K ﹤0.01% 1515
2016
Q4
$1.46M Buy
45,280
+1,118
+3% +$37.3K ﹤0.01% 1860
2016
Q3
$1.51M Buy
44,162
+949
+2% +$37.2K ﹤0.01% 1803
2016
Q2
$1.46M Buy
43,213
+428
+1% +$21K ﹤0.01% 1774
2016
Q1
$2.27M Sell
42,785
-14,698
-26% -$860K ﹤0.01% 1532
2015
Q4
$4.41M Buy
57,483
+15,867
+38% +$898K 0.01% 1281
2015
Q3
$1.71M Sell
41,616
-2,119
-5% -$130K ﹤0.01% 1674
2015
Q2
$3.09M Buy
43,735
+42,446
+3,293% +$3.34M ﹤0.01% 1632
2015
Q1
$115K Buy
+1,289
New +$131K ﹤0.01% 2213
2014
Q4
Sell
-14,405
Closed -$1.4M 2052
2014
Q3
$1.4M Hold
14,405
﹤0.01% 1758
2014
Q2
$1.32M Buy
+14,405
New +$1.1M ﹤0.01% 1802

Other funds holding PCRX